Effect of citric acid as cross-linking agent on insulin loaded chitosan microspheres

Iranian Polymer Journal (English Edition)

Volumn 14, Issue 7, 2005, Pages 647-656

  Varshosaz, Jaleh ^a   Alinagari, Reza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chitosan; Citric acid; Emulsification solvent evaporation; Insulin; Microspheres

Indexed keywords

CROSSLINKING; DISSOLUTION; INSULIN; PARTICLE SIZE ANALYSIS;

CITRIC ACIDS; CROSS-LINKING AGENT; INSULIN CHITOSAN;

ORGANIC ACIDS;

EID: 25144484349     PISSN: 10261265     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sawayanagi Y., Nambu N., Nagai T., Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin or chitosan, Chem. Pharmacol Bull., 31, 2064-2068 (1983).
2. Muzzarelli R., Chitosan. In: Muzzarelli R. (Eds.) Natural Chelating Polymers, Pergamon, Oxford, 144-176 (1973).
3. Dong Y.M., Qiu W.B., Ruan Y.H., Wu Y.S., Wang M.A., Xu C.Y., Influence of molecular weight on critical concentration of chitosan/formic acid liquid crystalline solution, Polym. J., 33, 387-389 (2001).
4. Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharmacol., 78, 43-48 (1992).
5. Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R., Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications, Eur. J. Pharm. Biopharm., 57, 19-34 (2004).
6. Nishioka Y., Kyotani S., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y., Ito K., Release characteristics of cisplatin chitosan microspheres and effect of containing chitin, Chem. Pharmacol Bull., 38, 2871-2873 (1990).
7. Thanoo B.C., Sunny M.C., Jayakrishnan A., Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for controlled release of pharmaceuticals, J. Pharm. Pharmacol., 44, 283-286 (1992).
8. Nishioka Y., Kyotani S., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y., Ito K., Release characteristics of cisplatin chitosan microspheres and effect of containing chitin, Chem. Pharm. Bull., 38, 2871-2873 (1990).
9. Jameela S.R., Jayakrishnan A., Glutaraldehyde crosslinked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle, Biomaterials, 16, 769-775 (1995).
10. Aydin Z., Akbuga J., Chitosan beads for the delivery of salmon calcitonin: Preparation and release characteristics, Int. J. Pharm., 131, 101-103 (1996).
11. Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J., Chitosan and chitosan/ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines, Pharm. Res., 14, 1431-1436 (1997).
12. Aiedeh K., Gianasi E., Orienti I., Zecchi V., Chitosan microcapsules as controlled release systems for insulin, J. Microencap., 14, 567-576 (1997).
13. Varshosaz J., Sadrai H., Alinajari R., Nasal delivery of insulin using chitosan microspheres, J. Microencap., 21, 761-774 (2004).
14. Lim L.Y, Wan L.S.C., Thai P.Y., Chitosan microspheres prepared by emulsification and ionotropic gelation, Drug Dev. Ind. Pharm., 23, 981-985 (1997).
15. Orienti I., Aiedeh K., Gianasi E., Bertasi V., Zecchi V., Indomethacin loaded chitosan microspheres. Correlation between the erosion process and release kinetics, J. Microencap., 13, 463-472 (1996).
16. Shu X.Z., Zhu K.J., Song W., Novel pH sensitive citrate cross-linked chitosan film for drug controlled-release, Int. J. Pharm., 212, 19-28 (2001).
17. Ugwoke I.M., Verbeke N., Kinget R., The biopharmaceutical aspects of nasal mucoadhesive drug delivery, J. Pharm. Pharmacol., 53, 3-22 (2001).
18. Phaechmud T., Koizumi T., Ritthidej G.C., Chitosan citrate as film former: compatibility with water-soluble anionic dyes and drug dissolution from coated tablet, Int. J. Pharm., 198, 97-111 (2000).
19. Cafaggi S., Leardi R., Parodi B., Caviglioli G., Russo E., Bignardi G., Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery, J. Control. Rel., 102, 159-169 (2005).
20. Park S.Y., Jun S.T., Marsh K.S., Physical properties of PVOH/chitosan-blended films cast from different solvents, Food Hydrocol., 15, 499-502 (2001).
21. Park S.Y., Lee B.I., Jung S.T., Park H.J., Biopolymer composite films based on K-carrageenan and chitosan, Mater. Res. Bul., 36, 511-519 (2001).
22. Leffler C.C., Müller B.W., Influence of the acid type on the physical and drug liberation properties of chitosangelatin sponges, Int. J. Pharm., 194, 229-237 (2000).
23. Muzzarelli C., Tosi G., Francescangeli O., Muzzarelli R.A.A., Alkaline chitosan solutions, Carbohyd. Res., 338, 2247-2255 (2003).
24. Shu X.Z., Zhu K.J., Controlled drug release properties of ionically cross-linked chitosan beads: The influence of anion structure, Int. J. Pharm., 233, 217-225 (2002).
25. Pereswetoff-Morath L., Microspheres as nasal drug delivery systems, Adv. Drug Del. Rev., 29, 185-194 (1998).
26. Illum L., Jorgensen H., Krogsgaard O., Rossing N., Bioadhesive microspheres as a potential nasal drug delivery system, Int. J. Pharm., 39, 189-199 (1987).
27. Illum L., Farraj N.F., Davis S.S., Chitosan as a novel nasal delivery system for peptide drugs, Pharm. Res., 11, 1186-1189 (1994).
28. Illum L., Farraj N.F., Davis S.S., Johansen B.R., O'Hagan D.T., Investigation of nasal absorption of biosynthetic human growth hormone in sheep-use of bioadhesive microsphere delivery system, Int. J. Pharm., 63, 207-211 (1990).
29. Illum L., Farraj N.F., Critchley J., Davis S.S., Nasal administration of gentamycin using a novel microsphere delivey system, Int. J. Pharm., 46, 261-265 (1988).
30. Farraj N.F., Johansen B.R., Davis S.S., Illum L., Nasal administration of insulin using bioadhesive microspheres as a delivery system, J. Cont. Rel., 13, 253-261 (1990).
31. Switzer R.L., Garrity L.F., Experimental Biochemistry, 3th ed. W.H. Freeman, New York, 22-24 (1999).
32. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Serkine K., Powder dosage form of insulin for nasal administration, J. Control. Rel., 1, 15-22 (1984).
33. Lachman L., Liberman H.A., Kanig J.L., The Theory and Practice of Industrial Pharmacy, Lea and Febiger, Philadelphia, 67 (1986).
34. Akbuga J., Bergisadi N., Effect of drug properties on physical and release characteristics of eudragit microspheres prepared by spherical crystallization techniques. Drug Dev. Ind. Pharm., 23, 407-411 (1997).
35. Banakar U.V., Pharmaceutical Dissolution Testing, Marcel & Dekker, New York, 192-193 (1992).
36. Khan K.A., The concept of dissolution efficiency, J. Pharm. Pharmacol., 27, 48-49 (1975).
37. Macheras P., Reppas C., Dressman B., Biopharmaceutics of Orally Administered Drugs, Ellis Horwood, London, 49-77 (1995).
38. Al-Helw A.A., Al-Angary A.A., Mahrous G.M., Al-Dardari M.M., Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone, J. Microencap., 15, 373-382 (1998).
39. Adusumilli P.S., Bolton S.M., Evaluation of chitosan citrate complexes as matrices for controlled release formulations using a 32 full factorial design, Drug Dev. Ind. Pharm., 17, 1931-1945 (1991).
40. Nigalaye A.G., Adusumilli P.S., Bolton S.M., Investigation of prolonged drug release from matrix formulations of chitosan, Drug Dev. Ind. Pharm., 16, 449-467 (1990).